Auxilium (AUXL +0.9%) ticks higher after BofA Merrill Lynch ups its price target on the shares...


Auxilium (AUXL +0.9%) ticks higher after BofA Merrill Lynch ups its price target on the shares to $28 from $24 on the back of yesterday's positive Phase 3 results of Xiaflex in fighting Peyronie's disease.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs